Back To Search Instructions
Protocols
8 protocols meet the specified criteria
Disease Site: Soft Tissue
Protocol No.TitleStatus
0500000013D9902: A COG Soft Tissue Biology and Banking ProtocolOpen
1501622398COG ARST1321: Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus PazopanibOpen
1606636756ARST1431: A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide Alternating with Vincristine and Irinotecan Versus VAC/VI Plus Temsirolimus in Patients with Intermediate Risk RhabdomyosarcomaOpen
1606665114A091304: A Phase I/ II Randomized Phase II Study of MLN0128 Vs. Pazopanib in Patients with Locally Advanced/ Unresectable and/or Metastatic SarcomaOpen
1704390293A Phase 1/2a Study of BMS-986205 Administered in Combination with Nivolumab anti-PD-1 Monoclonal Antibody) and in Combination with Both Nivolumab and Ipilimumab (anti-CTLA-4 Monoclonal Antibody) in Advanced Malignant TumorsOpen
1705411350A Randomized Phase III Trial Of TRC105 And Pazopanib Versus Pazopanib Alone In Patients With Advanced Angiosarcoma (Tappas) Open
PHXE-17-0216-10-15EAY131: Molecular Analysis for Therapy Choice (MATCH) Open
PHXE-17-0349-10-15DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare TumorsOpen